News From the Field

At present, NL SUPPORT and our partners through the Translational and Personalized Medicine Initiative are currently engaged in over two dozen applied health research projects. Many of these were reported on during the annual TPMI Research Day last October, and more again will appear in October 2016.

That's a lot of information to absorb. News From the Field is a regular feature in SUPPORT Letters, bringing you a quarterly update on one project at a time, so you can stay up-to-date on our progress. This month's update is from Dr. John-Michael Gamble, Assistant Professor in the School of Pharmacy:

Dr. Gamble is the principal investigator of our demonstration project on drug utilization by seniors. The overarching objective of this study is to examine the utilization of five important medication classes for individuals 65 years and older living within long-term care (LTC) facilities and those living in the community setting. Dr. Gamble and his team are at the data analysis stage and have identified trends in the use of these medication classes in LTC facilities throughout the province. Dr. Gamble is supported by a New Investigator Award in drug safety and effectiveness from the Canadian Institutes of Health Research and a Clinician Scientist Award from the Canadian Diabetes Association.
Dr. Gamble is also a member of the Drug Utilization Working Group, with representatives from NL SUPPORT, the School of Pharmacy, the NL Centre for Health Information and the provincial government, which facilitates and advises on projects investigating drug utilization, drug safety and cost-effectiveness. Together with the Drug Utilization Working Group, Dr. Gamble is working further to identify solutions to optimize prescription drug use in the province. NL SUPPORT looks forward to providing continuing support to Dr. Gamble as an intervention strategy is developed and results are disseminated.

Return to Vol1.1, Winter